David Henry Mack - Jul 1, 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: President and CEO, Director
Signature: /s/ Robert Ticktin, by power of attorney
Stock symbol: PMVP
Transactions as of: Jul 1, 2025
Transactions value $: -$62,179
Form type: 4
Date filed: 7/3/2025, 07:48 PM
Previous filing: Mar 5, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mack David Henry	President and CEO, Director	C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON	/s/ Robert Ticktin, by power of attorney	2025-07-03	0001341642

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Sale	-$62.2K	-58.4K	-9.82%	$1.06	536K	Jul 1, 2025	Direct	F1, F2
holding	PMVP	Common Stock						165K	Jul 1, 2025	See footnote	F3
holding	PMVP	Common Stock						148K	Jul 1, 2025	See footnote	F4
holding	PMVP	Common Stock						57K	Jul 1, 2025	See footnote	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
F2	Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
F3	The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4	The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F5	The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.